| Original language | English |
|---|---|
| Article number | 1297 |
| Journal | Cancers |
| Volume | 15 |
| Issue number | 4 |
| Number of pages | 20 |
| ISSN | 2072-6694 |
| DOIs | |
| Publication status | Published - Feb 2023 |
| MoE publication type | A2 Review article in a scientific journal |
Bibliographical note
Funding Information:V.C. was funded by the European Research Council under the European Union’s Horizon 2020 Framework program (H2020)/ERC-CoG-2015 Grant Agreement No. 681219, the Helsinki Institute of Life Science (HiLIFE), the Jane and Aatos Erkko Foundation (decision 19072019), and the Cancer Society of Finland (Syöpäjärjestöt). L.P. was funded by POR Campania FESR 2014/2020: Sviluppo di Approcci Terapeutici INnovativi per patologie neoplastiche resistenti ai trattamenti (SATIN).
Publisher Copyright:
© 2023 by the authors.
Fields of Science
- 3122 Cancers
- 317 Pharmacy
- oncolytic viruses (OVs)
- Epitope prediction
- Synthetic biology
- System biology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver